Home › Trial NCT05390112
Cohort Study of Patients With Hepatocellular Carcinoma and Circulating Tumor DNA Monitoring of Chemoembolization
- Trial IDNCT05390112
- StatusUnknown
- PhaseN/A
- Study typeObservational
- SponsorUniversity Hospital, Rouen
- Enrollment167
- Start date2021-05-20
- ConditionsCirculating Tumor DNA · Hepatocellular Carcinoma Non-resectable · Transarterial Chemoembolization
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.